MedPath

Safety assessment of the Yeast Extract containing nicotinamide mononucleotide (NMN)

Not Applicable
Conditions
Healthy volunteer
Registration Number
JPRN-UMIN000039527
Lead Sponsor
niversity of Toyama
Brief Summary

This clinical trial is terminated.

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete: follow-up complete
Sex
All
Target Recruitment
0
Inclusion Criteria

Not provided

Exclusion Criteria

1. Person with past treatment history of malignant tumor, heart failure, or myocardial infarction. 2. Person currently under treatment for atrial fibrillation, arrhythmia, hepatic dysfunction, renal dysfunction, cerebrovascular disorder, rheumatism, diabetes, dyslipidemia, hypertension, or other chronic diseases.3. Person with medication (including Kampo medicine). 4. Person with allergy against medicine or the test food 5. Pregnant, unwilling to practice contraception during the study, or lactating female 6. Person who is not judged as not qualified by the medical doctor.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Safety assessment (1) Physical measurements height, weight, body fat percentage, BMI, systolic blood pressure, diastolic blood pressure, heart rate (2) Blood test hematology: white blood cell count, red blood cell count, hemoglobin, Hematocrit, platelet count, MCV, MCH, MCHC b. Biochemical tests: TG, total cholesterol, LDL-cholesterol, HDL-cholesterol, free fatty acid, acetoacetic acid, 3-hydroxyacetic acid, total ketone body , lipoprotein (a), glucose, HbA1c, insulin, AST , AL T, gamma-GTP, ALP, LDH, total protein, albumin, uric acid, urea nitrogen, creatinine, sodium, chloride, potassium, calcium, inorganic phosphorus, magnesium (3) Urine testing Sugar, protein, urobilinogen, ketone body, pH, specific gravity, occult blood reaction, bilirubin, sediment (when protein is positive) (4) Diary
Secondary Outcome Measures
NameTimeMethod
Assessment the NAD-related metabolites in blood Blood NAD,NMN,nicotinamide,NA,NR,NAR,NAMN,NAAD
© Copyright 2025. All Rights Reserved by MedPath